Del Tacca M - Search Results

1

Biosimilar drugs : concerns and opportunities.

Genazzani AA, Biggio G, Caputi AP, Del Tacca M, Drago F, Fantozzi R, Canonico PL. Genazzani AA, et al. Among authors: del tacca m. BioDrugs. 2007;21(6):351-6. doi: 10.2165/00063030-200721060-00003. BioDrugs. 2007. PMID: 18020619 Review.

2

Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post-marketing clinical study on healthy volunteers.

Del Tacca M, Pasqualetti G, Di Paolo A, Virdis A, Massimetti G, Gori G, Versari D, Taddei S, Blandizzi C. Del Tacca M, et al. Br J Clin Pharmacol. 2009 Jul;68(1):34-42. doi: 10.1111/j.1365-2125.2009.03399.x. Br J Clin Pharmacol. 2009. PMID: 19660001 Free PMC article. Clinical Trial.

3

Healthy volunteers and early phases of clinical experimentation.

Pasqualetti G, Gori G, Blandizzi C, Del Tacca M. Pasqualetti G, et al. Among authors: del tacca m. Eur J Clin Pharmacol. 2010 Jul;66(7):647-53. doi: 10.1007/s00228-010-0827-0. Epub 2010 May 12. Eur J Clin Pharmacol. 2010. PMID: 20461363 Free article. Review.

4

Cholinergic toxic syndrome by the anticancer drug irinotecan: acetylcholinesterase does not play a major role.

Blandizzi C, Danesi R, De Paolis B, Di Paolo A, Colucci R, Falcone A, Del Tacca M. Blandizzi C, et al. Among authors: del tacca m. Clin Pharmacol Ther. 2002 Apr;71(4):263-71. doi: 10.1067/mcp.2002.121909. Clin Pharmacol Ther. 2002. PMID: 11956509

5

Pharmacokinetics and pharmacodynamics of combination chemotherapy with paclitaxel and epirubicin in breast cancer patients.

Danesi R, Innocenti F, Fogli S, Gennari A, Baldini E, Di Paolo A, Salvadori B, Bocci G, Conte PF, Del Tacca M. Danesi R, et al. Among authors: del tacca m. Br J Clin Pharmacol. 2002 May;53(5):508-18. doi: 10.1046/j.1365-2125.2002.01579.x. Br J Clin Pharmacol. 2002. PMID: 11994057 Free PMC article. Clinical Trial.

6

A pharmacokinetic-based test to prevent severe 5-fluorouracil toxicity.

Bocci G, Barbara C, Vannozzi F, Di Paolo A, Melosi A, Barsanti G, Allegrini G, Falcone A, Del Tacca M, Danesi R. Bocci G, et al. Among authors: del tacca m. Clin Pharmacol Ther. 2006 Oct;80(4):384-95. doi: 10.1016/j.clpt.2006.06.007. Clin Pharmacol Ther. 2006. PMID: 17015056

7

Clinical pharmacokinetics of irinotecan-based chemotherapy in colorectal cancer patients.

Di Paolo A, Bocci G, Danesi R, Del Tacca M. Di Paolo A, et al. Among authors: del tacca m. Curr Clin Pharmacol. 2006 Sep;1(3):311-23. doi: 10.2174/157488406778249307. Curr Clin Pharmacol. 2006. PMID: 18666754 Review.

8

Clinical pharmacokinetics of antibacterials in cerebrospinal fluid.

Di Paolo A, Gori G, Tascini C, Danesi R, Del Tacca M. Di Paolo A, et al. Among authors: del tacca m. Clin Pharmacokinet. 2013 Jul;52(7):511-42. doi: 10.1007/s40262-013-0062-9. Clin Pharmacokinet. 2013. PMID: 23605634 Review.

9

Limited sampling model for the analysis of 5-fluorouracil pharmacokinetics in adjuvant chemotherapy for colorectal cancer.

Di Paolo A, Danesi R, Vannozzi F, Falcone A, Mini E, Cionini L, Ibrahim T, Amadori D, Del Tacca M. Di Paolo A, et al. Among authors: del tacca m. Clin Pharmacol Ther. 2002 Dec;72(6):627-37. doi: 10.1067/mcp.2002.128867. Clin Pharmacol Ther. 2002. PMID: 12496744

10

Gastrin promotes human colon cancer cell growth via CCK-2 receptor-mediated cyclooxygenase-2 induction and prostaglandin E2 production.

Colucci R, Blandizzi C, Tanini M, Vassalle C, Breschi MC, Del Tacca M. Colucci R, et al. Among authors: del tacca m. Br J Pharmacol. 2005 Feb;144(3):338-48. doi: 10.1038/sj.bjp.0706053. Br J Pharmacol. 2005. PMID: 15655524 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

339 results

Search Page